)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
China Resources Sanjiu Medical & Pharmaceutical Co
China Resources Sanjiu Medical & Pharmaceutical Co (000999) investor relations material
China Resources Sanjiu Medical & Pharmaceutical Co Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary23 Oct, 2026
Executive summary
Q3 revenue was ¥6.396bn; YTD revenue reached ¥21.410bn, down 2.62% YoY. YTD net income attributable to shareholders was ¥2.158bn, down 8.30%.
YTD adjusted net income was ¥2.066bn, down 5.48%; adjusted Q3 net income was ¥469.5m, down 3.90%.
Financial highlights
Q3 net income attributable to shareholders was ¥486.9m, down 10.87% YoY; Q3 adjusted net income was ¥469.5m, down 3.90%.
YTD operating cash flow was ¥2.297bn, down 21.47% YoY.
YTD other income fell 37.12% to ¥149.9m, primarily reflecting lower government grants.
Key financial ratios and metrics
Basic and diluted EPS were ¥0.29 for Q3, down 9.38% YoY, and ¥1.30 YTD, down 8.45%.
Total assets were ¥55.437bn at quarter-end, down 5.73% from year-end; shareholder equity attributable to the parent was ¥22.625bn, up 2.04%.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from China Resources Sanjiu Medical & Pharmaceutical Co
- Net profit declined 7.96% despite revenue growth and strong prescription drug sales.000999
Q2 2026 - Revenue up 18.62% but net profit down 15.29% as costs and investments surged.000999Q1 2026
- 2025 revenue up 14.43%, net profit up 1.58%, with robust R&D and major acquisition.000999Q4 2025
- Revenue surged but profit declined as acquisition and investment costs rose sharply.000999Q3 2025
- Revenue up 4.99% but net profit down 24.31% as Tasly acquisition reshapes business.000999Q2 2025
- Net profit jumped 23.19% year-over-year, with strategic M&A and innovation fueling growth.000999Q3 2024
- H1 2024 net profit rose 27.8% on 7.3% revenue growth, driven by CHC business strength.000999H1 2024
- Revenue and profit declined, but asset growth and Tasly integration drive future potential.000999Q1 2025
- Revenue and net profit surged on strong CHC and prescription drug growth, with a 50% payout.000999Q4 2024
Next China Resources Sanjiu Medical & Pharmaceutical Co earnings date
Q4 202612 Mar, 2027
China Resources Sanjiu Medical & Pharmaceutical Co
Next China Resources Sanjiu Medical & Pharmaceutical Co earnings date
Q4 202612 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is engaged in the research, development, production, and distribution of pharmaceutical products. The company offers a range of prescription and over-the-counter (OTC) medications, as well as traditional Chinese medicine (TCM) products. Its offerings are used to treat various health conditions, including respiratory, digestive, and chronic diseases. The company is headquartered in Shenzhen, China, and its shares are listed on the SZSE.